Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Nebraska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Nebraska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Nebraska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Timothy Huyck (NPI 1376760991)

Field	Value
Entity Type	Individual
Organization	Timothy Huyck
Address	611 Fenwick Dr
City	Papillion
State	NE
ZIP	68046
Taxonomy	Internal Medicine Physician
NPI Enumerated	April 18, 2007

Payer Source	Total Paid
Medicare	$855.4K
Medicaid	$0

Key Findings

This provider’s Medicare revenue is concentrated heavily in a small set of services: the top 3 Medicare codes account for 84.5% of total Medicare revenue, and J9271 (pembrolizumab) alone represents $579.9K or 68.6% of the $855.4K lifetime Medicare revenue. That concentration indicates the practice’s financial performance is driven primarily by expensive oncology drug administration rather than a broad mix of office-based E/M billing.

The CPT/HCPCS mix points to an outpatient oncology/infusion practice model: high-revenue drug administration code J9271 is paired with chemotherapy administration codes such as 96413 and G0498 and multiple chemo add-on codes (96417, 96411, 96415). These procedure and infusion codes, together with frequent lab panels and access maintenance codes, imply on-site infusion services and clinical workflows centered on systemic cancer therapies.

Payer mix is effectively single-payer Medicare at the provider level: lifetime Medicare revenue is $855.4K while Medicaid shows none on file, so analysts should treat this entity as primarily Medicare-serving for payer strategy and network planning. The absence of Medicaid activity means comparisons to in-state Medicaid volumes are not applicable.

Competitive standing for the principal drug is moderate: J9271 ranks #770 of 1841 nationally and is characterized as “typical, unremarkable volume,” so while pembrolizumab is the dominant revenue source for this provider, the provider is not a national high-volume outlier for that drug. In contrast, other parts of the mix show different competitive signals that affect how the practice is positioned in the market.

Office visit E/M billing shows unusually high established-patient volume: 99214 appears with 1.2K claims and $105.6K revenue and is labeled an “extreme outlier, far above typical national volume,” while 99215 is also elevated (93rd percentile, typical label). This pattern suggests a large established patient panel or repeated follow-up encounters that accompany ongoing infusion care, making clinic throughput and scheduling a likely operational focus.

Ancillary and support services align with an infusion-centered operation: high counts for lab codes 85025 and 80053 (CBC and CMP) and a notable volume for venous access maintenance 96523 (ranked 63 of 1643 and described as “notably above typical national volume”) indicate routine lab monitoring and frequent access/device maintenance consistent with chemotherapy/infusion workflows. These ancillary services contribute operational stickiness and incremental revenue around the core drug administration activity.

The provider has long tenure in the Medicare system—NPI enumerated 2007-04-18 (~19 years ago)—which, combined with $855.4K in lifetime Medicare revenue, indicates an established billing history. Taken together with the concentrated oncology-focused code mix, this suggests a stable, mid-sized Medicare practice that has specialized over time in infusion-based oncology care rather than broad primary care or procedural diversification.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

46 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	13,810	$40	$579.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,210	$90	$105.6K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	220	$130	$28.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	280	$100	$26.5K
J1439	Injection, ferric carboxymaltose, 1 mg	25,500	$1	$25.5K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	50	$160	$8.6K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community…	70	$120	$8.4K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	980	$10	$7.8K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	620	$10	$6.2K
99232	The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or…	100	$60	$6K

Showing 1–10 of 46

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 46 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Nebraska Distribution

Timothy Huyck — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Nebraska

Full comparison — all codes billed, vs. state median

46 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	16	30	14,400	$40	$671.6K
J1439	16	30	25,880	$1	$26.4K
96413	30	80	60	$90	$18.2K
99214	43	3,210	110	$70	$14.9K
99233	722	830	80	$90	$11.7K
J3490	30	30	60	$160	$11.3K
88185	12	10	480	$20	$9.1K
99232	566	1,390	80	$60	$8.6K
99213	1,763	3,220	90	$50	$7.9K
99215	46	920	40	$110	$7K

Showing 1–10 of 46

Related Providers

Other providers that share a Tax Identification Number (TIN) with Timothy Huyck, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Stefano Tarantolo	NE	Hematology & Oncology Physician	$3.2M	$0
Samuel Mehr	NE	Nuclear Medicine Physician	$2.5M	$0
Ralph Hauke	NE	Hematology & Oncology Physician	$2.5M	$0
Gamini Sooriyaarachchi	FL	Medical Oncology Physician	$2.2M	$0
Ryan Ramaekers	NE	Hematology & Oncology Physician	$2.1M	$0
Joel Michalski	NE	Internal Medicine Physician	$2M	$0
Yungpo Su	NE	Hematology & Oncology Physician	$1.9M	$0
Margaret Block	NE	Hematology & Oncology Physician	$1.7M	$0
Robert Langdon	NE	Hematology & Oncology Physician	$1.4M	$0
Muhammad Haroon	NE	Hematology & Oncology Physician	$1.4M	$0

Nearby Providers

Other providers in the same ZIP code as Timothy Huyck, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Alegent Creighton Health	NE	General Acute Care Hospital	$0	$3M
Pediatric Therapy Center	NE	Pediatric Occupational Therapist	$0	$2.6M
Jane Bennett	NE	Pediatric Dentistry	$0	$2.6M
Alegent Creighton Health	NE	Community/Retail Pharmacy	$0	$822.1K
City Of Papillion	NE	Land Ambulance	$413.7K	$394.8K
Bellevue Oral And Maxillofacial Surgery LLC	NE	Dental Clinic/Center	$0	$684.5K
Ambi's Home Health Care, LLC	NE	Home Health Agency	$0	$661.3K
New Century Physicians Of Nebraska LLC	NE	Emergency Medicine Physician	$0	$460.2K
Barry Webber	NE	Pediatric Dentistry	$0	$363.7K
Wright Turn Lane PC	NE	Urgent Care Clinic/Center	$0	$360.5K

Timothy Huyck — Billing Profile & Reimbursement Data

Sign up for Timothy Huyck — Billing Profile & Reimbursement Data policy alerts

Timothy Huyck — Billing Profile & Reimbursement Data

Sign up for Timothy Huyck — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References